StreetInsider.com News Articles

Form EFFECT Aura Biosciences, Inc.

Fri, 21 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260821/26958190.html

Form EFFECT Aura Biosciences, Inc.

Fri, 21 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260821/26958190.html

Form SCHEDULE 13G/A Aura Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.

Fri, 14 Aug 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260814/26931603.html

Form SCHEDULE 13G/A Aura Biosciences, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.

Fri, 14 Aug 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260814/26931603.html

Form SCHEDULE 13G Aura Biosciences, Inc. Filed by: Long Focus Capital Management, LLC

Fri, 14 Aug 2026 06:09:00 -0400

si-local-file:///var/storage/secattach/20260814/26924121.html

Form SCHEDULE 13G Aura Biosciences, Inc. Filed by: Long Focus Capital Management, LLC

Fri, 14 Aug 2026 06:09:00 -0400

si-local-file:///var/storage/secattach/20260814/26924121.html

Form 3 Aura Biosciences, Inc. For: Aug 12 Filed by: Person Julie

Wed, 12 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260812/26913115.html

Form 3 Aura Biosciences, Inc. For: Aug 12 Filed by: Person Julie

Wed, 12 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260812/26913115.html

Form 3 Aura Biosciences, Inc. For: Aug 10 Filed by: Kratz Erica

Wed, 12 Aug 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260812/26912979.html

Form 3 Aura Biosciences, Inc. For: Aug 10 Filed by: Kratz Erica

Wed, 12 Aug 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260812/26912979.html

Form 3 Aura Biosciences, Inc. For: Aug 10 Filed by: Abu-Absi Susan

Wed, 12 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260812/26912732.html

Form 3 Aura Biosciences, Inc. For: Aug 10 Filed by: Abu-Absi Susan

Wed, 12 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260812/26912732.html

Form SCHEDULE 13G/A Aura Biosciences, Inc. Filed by: Adage Capital Management, L.P.

Wed, 12 Aug 2026 12:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26911218.html

Form SCHEDULE 13G/A Aura Biosciences, Inc. Filed by: Adage Capital Management, L.P.

Wed, 12 Aug 2026 12:03:00 -0400

si-local-file:///var/storage/secattach/20260812/26911218.html

Aura Biosciences (AURA) PT Lowered to $18 at H.C. Wainwright

Wed, 12 Aug 2026 07:26:41 -0400

(Updated - August 12, 2026 7:26 AM EDT)

H.C. Wainwright analyst Andreas Maldonado lowered the price target on Aura Biosciences (NASDAQ: AURA) to $18.00 (from $24.00) while maintaining a Buy rating.

The analyst commented: "With enrollment now complete, investor focus has shifted to whether CoMpass is designed to deliver a registrationally meaningful outcome. We believe it is, and revisit that view through our updated work on the Phase 3 statistical plan later in this note. For context, the Phase 3 CoMpass trial completed enrollment this past June with 108 patients and remains on track for topline data in 2H27. The global, multi-institutional

Aura Biosciences (AURA) PT Lowered to $18 at H.C. Wainwright

Wed, 12 Aug 2026 07:26:41 -0400

(Updated - August 12, 2026 7:26 AM EDT)

H.C. Wainwright analyst Andreas Maldonado lowered the price target on Aura Biosciences (NASDAQ: AURA) to $18.00 (from $24.00) while maintaining a Buy rating.

Aura Biosciences (AURA) files $500M mixed shelf

Tue, 11 Aug 2026 16:20:17 -0400

Aura Biosciences (NASDAQ: AURA) filed $500,000,000 mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Units

Aura Biosciences (AURA) files $500M mixed shelf

Tue, 11 Aug 2026 16:20:17 -0400

Aura Biosciences (NASDAQ: AURA) filed $500,000,000 mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Units

Form S-3 Aura Biosciences, Inc.

Tue, 11 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260811/26906009.html

Form S-3 Aura Biosciences, Inc.

Tue, 11 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260811/26906009.html

Aura Biosciences, Inc. (AURA) Misses Q2 EPS by 7c

Tue, 11 Aug 2026 07:38:45 -0400

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q2 EPS of ($0.48), $0.07 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

Form 10-Q Aura Biosciences, Inc. For: Jun 30

Tue, 11 Aug 2026 07:16:00 -0400

si-local-file:///var/storage/secattach/20260811/26901338.html

Form 10-Q Aura Biosciences, Inc. For: Jun 30

Tue, 11 Aug 2026 07:16:00 -0400

si-local-file:///var/storage/secattach/20260811/26901338.html

Form 8-K Aura Biosciences, Inc. For: Aug 11

Tue, 11 Aug 2026 07:06:00 -0400

si-local-file:///var/storage/secattach/20260811/26901273.html

Form 8-K Aura Biosciences, Inc. For: Aug 11

Tue, 11 Aug 2026 07:06:00 -0400

si-local-file:///var/storage/secattach/20260811/26901273.html